INTRODUCTION
During normal development in mammals, the eyelids grow across the eye, fuse, and subsequently reopen. In mice, the periderm forms an outer layer of the epidermis on days 10 and 11 of gestation (E10 and E11). It is one-cell thick and covers the outer surface of the embryo from day E12 until it is shed on day E17. During this period the underlying epidermis rapidly proliferates and differentiates to become a stratified, keratinized epithelium. The upper and lower eyelids are fused to each other on day E16.5 and reopen on about postnatal day (P) 14 (Harris and Juriloff, 1986) . The gaping lids (gp) or lidgap-Gates (lgGa) mutations, which cause the eyelids open at birth phenotype in mice, were discovered in 1961. They exhibit autosomal recessive inheritance spontaneously developed from C57BL/6-ax stain mice with 100% penetrance (Ricardo and Miller, 1967) . The mutant gene was mapped to a chromosome between D13Mit76 (62.35 cM) and D13Mit53 (63.73 cM) using microsatellite genetic markers. There is a 27.5-kb deletion including exons 2-9 in the Map3k1 gene of lgGa mice (Juriloff et al., 2005) .
Mice with eyelids open at birth are generally referred to as having an eye open at birth (EOB) phenotype. EOB mice gradually develop corneal disease, which mainly presents as keratitis and corneal opacity. The developmental process of this phenotype mimics relevant diseases in humans. Therefore, the EOB mouse model is very useful for characterization of the molecular mechanisms underlying the process of eyelid closure and fusion.
In our previous study, heredity C57BL/6J-corneal opacity (B6-Co) mice were generated by administering N-ethyl-N-nitrosourea (ENU) (100 mg/kg) to wild-type C57BL/6 mice (Shao et al., 2006) . The eyes of these mice were open at birth, and the cornea gradually became opaque. The mutant gene was located between 112,546,283 and 113,397,654 bp on chromosome 13, determined by single nucleotide polymorphism (SNP) fine mapping (Jiang et al., 2010) . In the present study, histochemical analysis was conducted to phenotypically characterize B6-Co mice at different embryonic stages. The wound healing assay, 5-bromo-2-deoxyuridine (BrdU) staining, and TUNEL assay were used to investigate migration, proliferation, and apoptosis, respectively, of keratinocytes in the eyelids of B6-Co mice. Reverse transcription-polymerase chain reaction (RT-PCR) was used to test the expression of genes involved in eyelid development. B6-Co mice are an excellent model for investigating the mechanisms of eyelid development, and exploring drug targets for treating human cornea matrix denaturalization.
MATERIAL AND METHODS

Laboratory animals
B6-Co, a mutant mouse model on a C57BL/6J (B6) background, and wild-type B6 mice were both obtained from the Laboratory Animal Center of Nantong University. Mice were kept in a barrier system at 23° ± 2°C with humidity of 55 ± 5%. The mice were maintained under a 12-h light/12-h dark cycle with free access to radiation-sterilized food (Shuangshi, Suzhou, China) and sterile water.
All experimental procedures involving animals were conducted in accordance with the Institutional Animal Care guidelines, and were ethically approved by the administration committee of experimental animals, Jiangsu Province, China.
Phenotypic characterization
The corneal opacity of B6-Co mice was examined under a slit lamp. Fetuses of E14.5-P0 were sacrificed by decapitation, and heads were collected for phenotypic characterization. The heads of fetuses were fixed in 4% paraformaldehyde overnight at 4°C, dehydrated with a graded sucrose solution series, and embedded in Tissue Freezing Medium (O.C.T). Tissues were then cut into 8-mm thick frozen sections using a freezing microtome of Leica CM1900 (Leica, Solms, Germany). The sections were then subjected to hematoxylin and eosin (H&E) staining before acquiring images using a color digital camera. The tissue sections were incubated with FITC-phalloidin and Hoechst 33342 (Sigma, San Jose, CA, USA) and observed under a fluorescence microscope of Olympus cxk41 (Olympus, Tokyo, Japan).
Cell culture
Primary mouse epidermal keratinocytes and dermal fibroblasts were prepared from B6 and B6-Co E16.5 fetuses. B6-Co pups displayed the EOB phenotype. Keratinocytes were prepared as previously described (Zhang et al., 2003b) and all cell culture reagents were obtained from Hyclone (Hyclone, Logan, UT, USA).
In vitro wound-healing assay
Confluent monolayers of B6 and B6-Co epidermal keratinocytes and dermal fibroblasts were starved in growth factor-free media for 24 h before being wounded by scratching the monolayer with a micropipette tip. The wounded cells were then washed, and cultured at 37°C in the appropriate media with or without growth factors. Images of the wounded area were acquired 24 h after wounding.
BrdU incorporation
The proliferation of keratinocytes was determined using a BrdU labeling/detection kit (Sigma), according to the manufacturer instructions. After BrdU labeling, the keratinocytes were observed under a fluorescent microscope. The percentage of BrdU-positive cells was calculated from 10 random fields in 3 wells.
In vitro apoptosis assay
Keratinocytes isolated from the eyelids of E16.5 mice were used to detect apoptotic cells. A TUNEL assay was performed on samples using the One Step TUNEL Apoptosis Assay Kit, according to the manufacturer instructions (Beyotime, Haimen, China).
Sequence analysis and real-time PCR
Total RNA was isolated from B6-Co and B6 embryos using the TRIzol kit, according to the manufacturer instructions (Invitrogen, Carlsbad, CA, USA). Full-length cDNA was synthesized using RevertAid TM M-MuLV reverse transcriptase (Fermentas, Burlington, Canada) and was then amplified by PCR using Taq polymerase (Fermentas, Burlington, Canada) . The primers were designed using the Primer Prepmer 5.0 software (Premier, Toronto, Canada) ( Table 1 ). The RT-PCR products for Fgf10, and Mtap1B were 1138 and 938 bp, respectively. PCR products were gel purified using the EZ Spin Column DNA Gel Extraction Kit (Sangon, Shanghai, China), and recombinant vectors were transformed in competent cells after DNA fragments were cloned into the pGEM-T vector (Promega, Madison, WI, USA). Positive clones were identified by EcoRI restriction endonuclease digestion and sequence analysis (Sangon).
Total RNA were extracted from eyelid tissues in B6-Co and B6 embryos for real-time PCR using Fast EvaGreen ® qPCR Master Mix (Biotium, Hayward, CA, USA). The primers were designed using the Primer Prepmer 5.0 software ( Table 1 ). The PCR products for Gapdh, Hbegf, Rock1, Map3k1, and Jnk1 were 133, 182, 117, 172, and 162 bp, respectively. The reactions were cycled 45 times under the appropriate parameters for each pair of primers and the fluorescence was measured every 15 s at the end of each cycle to construct the amplification curve. All determinations were performed at least in triplicate. The relative expression of mRNAs was calculated using the comparative 2 -DDCt method and normalized against Gapdh. 
Statistical analysis
All data are reported as means ± SE of three independent experiments (each in duplicate). One-way ANOVA and the post hoc Scheffe test were used for statistical analysis using the Stata 6.0 software package (Stata, College Station, TX, USA). P values <0.05 were considered to be statistically significant.
RESULTS
Eyelid closure defect at birth in B6-Co mice B6 mice were crossed with B6-Co mice to generate normal wild-type and B6-Co phenotype mice. To define the pathological structure of the eyelid defect in B6-Co mice, we initially analyzed the histology of eyelid formation and development. The phenotype of embryonic eyelids in B6-Co mice was extremely similar to that in B6 mice at E14.5 ( Figure  1AI -III and BI-III). However, at E16.5, the ocular surface in B6 mice was covered by a thin epithelium that extended from the tip of the developing eyelid, described as membrane-like eyelids ( Figure 1CI -III). In contrast, the eyelids of B6-Co grew more slowly than that of B6 ( Figure 1DI ), leaving the ocular surface exposed ( Figure 1DII and DIII), and this corresponded with the development process ( Figure 
Eyelids open at birth and the cornea gradually becomes opaque in B6-Co mice
The eyelids are tightly closed at birth ( Figure 2AI ) and reopen approximately at P14 in B6 mice. Furthermore, cornea development was normal in B6 mice ( Figure 2AII and AIII). However, the eyelids opened at birth ( Figure 2BI ) in B6-Co mice, leaving the cornea exposed, leading to gradual opacity ( Figure 2BII and BIII) and neovessel formation ( Figure  2BIII , arrowhead). Previous studies indicate that the EOB phenotype completely correlates with corneal opacity in B6-Co mice (Jiang et al., 2010) . B6-Co mice with abnormal eyelid development suffer from infection of the cornea, and its epithelium is destroyed by P3. Corneal opacity gradually develops by P10, when neovessels appear, as described in our previous study (Tang et al., 2008) . 
Defects in F-actin development in leading edge cells of B6-Co mice
Development of the eyelid requires coordination of the cellular processes of proliferation, cell morphology, migration, and cell death. Cell migration was related to morphous changes of actin filaments, which significantly affect the cytoskeleton (Lin et al., 2015) . We detected morphous F-actin filaments in the eyelids of mice at different embryonic stages using FITC-phalloidin staining. At E16.5, the shape of the cytoskeleton of leading edge cells was similar to the ellipse or spindle shape observed in B6 eyelids ( Figure 3AI , arrowheads). F-actin bundles were assembled, recombination and extension continually, which elongated the cells ( Figure 3AII and AIII). The continuous forward movement of upper and lower eyelids was based on cell proliferation and continual extension. In contrast, there were very few F-actin bundles assembled in the leading edge cells, and the cells exhibited a round pie shape with tightly arranged F-actin bundles in B6-Co mice ( Figure 3BI-III) . The tip of the leading edge ( Figure 3AII , red arrowhead) had a sharp peak shape that allowed forward movement in B6 mice. In contrast, a blunt terminal was observed in B6-Co mice ( Figure 3BII .5: the cell morphology was different between B6 and B6-Co mice (arrowheads), and the cytoskeletal morphological difference was significant between AI and BI, and there were F-actin bundles assembled in a similar ellipsoidal shape in the AI cells in the stretch state but not in the same state in BI. A series of cells compose the leading edge near the dotted line. The red arrowhead shows the tip of the leading edge in AII, and the inner dotted line represents mesenchyme. C. and D. E18.5: the leading edges of the upper and lower eyelids were closer in CII, and the cytoskeleton morphology between CI and DI was not significantly different from AI and BI. E. and F. P0: the upper and lower eyelids remain closed in EI, and the cytoskeleton morphology was not significantly different from FI. The leading edge was not obvious in FII. The light degree of Hoechst staining and the nuclear density were not significantly different between B6 and B6-Co from II.
Proliferation and migration of keratinocytes isolated from B6-Co mice
To investigate the mechanisms underlying the defects in eyelid development in B6-Co mice, BrdU incorporation and wound healing assays were used to assess the proliferation and migration of keratinocytes isolated from the eyelids of B6-Co mice. The in vitro BrdU incorporation assay demonstrated no significant difference (P = 0.069) in keratinocyte proliferation between B6 and B6-Co mice at E16.5 (Figure 4) . However, keratinocyte migration was decreased in B6-Co mice compared to B6 mice (P = 0.012), which was detected 24 h after scratching in an in vitro wound healing assay ( Figure 5 ). Furthermore, B6 and B6-Co keratinocytes at E16.5 were subjected to a TUNEL assay to examine apoptosis around the eyelid tissues. However, no significant difference (P = 0.371) in apoptosis was observed between the keratinocytes isolated from B6-Co and B6-Co mice at E16.5 ( Figure 6 ). . Keratinocyte migration in B6 and B6-Co mice using an in vitro wound healing assay. Confluent monolayers of B6 and B6-Co mice epidermal keratinocytes were subjected to in vitro wound-healing assays in medium without growth factors. Images were acquired 24 h after wounding. Error bars represent means ± SD from three independent experiments. *P = 0.012 versus B6. Figure 6 . TUNEL staining. Keratinocytes of B6 and B6-Co mice at E16.5 were subjected to a TUNEL assay to examine apoptosis around the eyelid tissues. Positive controls were eyelid tissues treated with DNase I. Scale bar: 200 mm.
Mutant gene mapping and candidate gene analysis
We previously showed that the mutant gene causing the EOB phenotype was roughly mapped to chromosome 13 (Shao et al., 2006) , and further mapped between two SNPs, rs29492976 and rs29620530 (112,546,283 and 113,397,654 bp) , by SNPs rs29235242, rs29492976, rs29620530, rs29778277, and rs13466915 (Jiang et al., 2010 ). There were two candidate genes, Map3k1 and Il6st, in the mapping range, and the Map3k1 gene was shown to be the candidate gene responsible for the EOB phenotype by Map3k1 knockout studies (Meng et al., 2014) . Il6st knockout mice exhibited a blind phenotype induced by retinopathy (ChucairElliott et al., 2012). However, B6-Co mice exhibit dominant heredity. Specifically, a single copy mutant gene was sufficient to display the EOB phenotype in B6-Co mice. In contrast homozygous MEKK1 DKD/DKD was required for the EOB phenotype in Map3k1 knockout mice (Meng et al., 2014) .
A sequence analysis for Map3k1 and Il6st genes in B6-Co mice showed no mutations. However, Fgf10 (67.14 cM) and Plk2 (61.9 cM) genes, which are associated with eyelid development, were found near the mapping region. The Mtap1B (52.9 cM) gene regulates microtubular recombination. Furthermore, Mtap1B knockout mice developed blindness due to retinopathy (Meixner et al., 2000; Ma et al., 2003; Tsau et al., 2011) . RT-PCR and sequencing analysis were used to confirm mutations in Fgf10 ( Figure 7A and B), Plk2 (data not shown), and Mtap1B ( Figure 7F and G) genes, all of which are involved in eyelid development in B6-Co mice. The results of sequencing showed that there was an insertion mutation in the 3'-untranslated region (UTR) of the Fgf10 gene ( Figure 7E) . Sequencing of the RT-PCR product of Mtap1B ( Figure 7F ) demonstrated an A2333T mutation in the coding region of the Mtap1B gene ( Figure 7G ) in B6-Co mice ( Figure 7H, arrowhead) . However, no mutations were identified in the Plk2 gene of B6-Co mice (data not shown). To confirm the mutations identified in Fgf10 and Mtap1B genes of B6-Co mice, we analyzed ten B6-Co samples, and determined that the mutation rate was 80% in the Mtap1B gene and 70% in Fgf10 (Table 2 ). 
Gene name
Location (cM) Mutation in 10 samples ("+" normal, "-" mutant) Protein coding change Mtap1B Fgf10 52.9 67.14 --+ ---+ ----+ ---+ + ---yes no
It was reported that down-regulation of Hbegf and Mtap1B mutation was involved in eyelid development defects in B6-Co mice (Hayashi et al., 2005; Pacal and Bremner, 2014) . Hbegf, Rock1, Map3k1, and Jnk1 genes are key factors for eyelid development. To understand the molecular mechanisms underlying the process of eyelid development, we checked the expressions of these genes in the eyelids of B6-Co mice at different embryo stages by real-time PCR. Compared to B6 mice, expression of the Hbegf gene was significantly down-regulated (P = 0.043) in B6-Co at E16.5 (Figure 8 ). However, no significant changes in the expression of Rock1, Map3k1, and Jnk1 genes were observed between B6 and B6-Co mice (P > 0.05; Figure 8 ). Figure 1C and D) , and that their corneas gradually become opaque ( Figure 2B ). The phenotype of B6-Co mice was similar to various gene knockout mice, including Egfr, Tgfa, Fgfr2, Map3k1, Hbegf, c-jun, Lgr4, and Rock1 knockouts (Li et al., 2003; Mine et al., 2005; Thumkeo et al., 2005; Kato et al., 2007; Pennock et al., 2011; Martínez-Abadías et al., 2013; Meng et al., 2014; Sanderson et al., 2014) . Interestingly, B6-Co eyelids were developmentally similar to that of wild-type B6 mice at E14.5. Therefore, it was difficult to distinguish between them at this stage ( Figure 1A and B). However, at E16.5, the eyelids of B6-Co mice demonstrated significant retardation in development and did not close, compared to B6 mice ( Figure 1C and D) . After E16.5, eyelid growth was slowed during development in B6-Co mice, and the eyelids remained open even at P0 (Figure 1E-H) . It has been reported that the best time for eyelid closure is about E16.5, at which time the cornea and other eye accessory structures involved in gradual development could interfere with fusion of the upper and lower eyelids (McCauley et al., 2014; Heude et al., 2015) . The eyelids of B6-Co mice grew slowly, and therefore missed the ideal period for eyelid fusion, demonstrating temporal and spatial specificity in embryonic development.
The developing eyelids are composed of loose mesenchyme covered by an epithelial sheet, the epidermis (outer surface), and conjunctiva (inner surface), as well as the periderm, which covers the epidermis (Deng et al., 2006) . Only the peridermal and epidermal layers are involved in eyelid fusion. The mesenchymal layers of the upper and lower eyelids remain separate. A profusion of rounded periderm cells then appear, and pile up at the leading edges of the advancing eyelids during eyelid growth (Zhang et al., 2003b) . Once contact is made between the opposed eyelids, these cells flatten and form a strip along the fusion line, until they slough off with the rest of the periderm on day 17 of gestation (Zhang et al., 2005) . It is evident that the eyelids fused and reopened from the embryonic stage to about P14 to protect internal composition in the eye, especially the cornea. The eyelids were tightly closed at birth ( Figure 1GIII ). This was possibly the result of biological evolution, and we speculate that the eyeball was placed into physical homeostasis before the eyelids reopened. In contrast, eyelids opened at birth in B6-Co mice. The failure of this protection system in B6-Co mice leaves eyeballs exposed to an external environment, resulting in ocular diseases. The cornea gradually became opaque with neovessel formation observed ( Figure 2BIII ). This may be due to infectious materials in the housing cage and the environment. This phenotype was similar to that observed in Tgfa-deficient mice (Pennock et al., 2011) .
Development of corneal opacity was due to the environment or to a concurrent internal gene defect. Here, MEKK1-deficient mice were used to investigate the mechanism of corneal opacity formation. Several studies have shown that MEKK1 is required for B and T cell activation (Zhang et al., 2003a; Labuda et al., 2006; Kim et al., 2007) . MEKK1 is necessary for CD40-mediated activation of Jnk and p38 kinases, and it is an essential component of signaling cascades involved in thymus-dependent antigen-induced B cell proliferation and antibody production (Gallagher et al., 2007) . The MEKK1 kinase domain has been shown to be important for IL4 and IL6 gene expression under Th2 conditions (Enzler et al., 2009) . Therefore, defects in immune function could account for corneal opacity, as well as the EOB phenotype in MEKK1-deficient mice. Further studies are needed to determine the effects of defects on the immune protective function, and the influence on defective corneal development.
Cell migration is required for upper and lower eyelid growth and development. Some EOB mice exhibit impaired cell migration in keratinocytes and fibroblasts cultured in vitro. Cell migration is also closely related to cell morphology, therefore the morphology of the cytoskeleton or microfilament bundles has been used to determine cell migration (Jin et al., 2008; Rice et al., 2012) . MEKK1
-/-cells have a flattened "pancake"-like morphology, whereas wild-type cells have a more spindle morphology, with a characteristic leading edge and tail (Yujiri et al., 1998) . In the present study, the morphology of F-actin bundles and the nucleus exhibited a spindle shape in the leading edge of B6 mice, but a round shape in B6-Co mice (Figure 3 ). Laser-ablation experiments have shown that actin cables can generate a contractile force, which is responsible for movement of the epithelial sheet during dorsal closure, thereby functioning in a manner analogous to a purse string (Hutson et al., 2003) . It is possible that the "string" is defective in B6-Co mice, and we propose that the structure or driving force led to the defective "string". This driving force was possibly impaired in Rock1 -/-mice . Actin filaments were observed to be in an extended state in the leading edge of B6 mice ( Figure 3AII ). Therefore, we propose that the leading edge likely plays a "vanguard" role in the forward movement of the eyelids. The distinction in actin filament shape between B6 and B6-Co was evident at E16.5 and gradually decreased at E18.5 and P0 ( Figure 3CII , DII, EII, and FII). The shape of the leading edge was blunt in B6-Co mice ( Figure 3BII , arrowheads) but had a sharp tip in B6 mice ( Figure 3AI ), suggesting that migration direction of the leading edge was probably impaired in B6-Co mice. The development eyelids were divided into three fine structures, including root region (Figure 3 (1) and (2), arrowheads), mesenchyme ( Figure 3AII ), and leading edge ( Figure 3II, dotted line) . Growth factors such as FGF10 from mesenchyme cells arrived at the leading edge and promoted their proliferation and migration (Tao et al., 2005) . Keratinocyte migration was defective in B6-Co mice.
Cell proliferation and apoptosis were required for eyelid development and migration. A previous study showed that impaired cell proliferation was associated with eyelid closure (Mongan et al., 2011) . Other studies also reported that apoptosis affects this process. According to our results, apoptosis and proliferation are not involved in eyelid fusion failure.
The process of eyelid development demonstrated temporal and spatial specificity in mice. Several necessary factors enhanced eyelid fusion in wild-type mice. In contrast, absence or shortage of these necessary factors was observed in the eyelids of gene-deficient mice. Furthermore, tissue specific of cornea was observed near the eyelids and no abundant alternative compensatory factors were identified. Therefore, the epithelium in eyelids moved very slowly. There was no significant difference in cell migration ability, as determined using a wound-healing assay, between adult wild-type and MEKK1 -/-mice exhibiting the EOB phenotype (Deng et al., 2006) . It is likely that abundant subcutaneous cytokines may serve as an alternative pathway to promote wound healing. A similar experiment was performed in Rock1 -/-mice, ROCK1 was not required for wound healing in adult skin, which further indicated that eyelid development was a process of temporal and spatial specificity in mice . Necessary factors for eyelid development can be applied to eyelid tissue in vitro in order to study the mechanism of action of these factors in eyelid development (Tao et al., 2005) . Eyelid tissue culture in vitro vividly exhibits eyelid development, as well as temporal and spatial specificity, compared to keratinocytes cultured in vitro.
Mapping and identification of mutant genes are difficult using a phenotype driving method. B6-Co mice are a mutant strain induced by ENU administration. The mutant gene is located between 112,546,283 and 113,397,654 bp on chromosome 13 by SNPs (Jiang et al., 2010) . Moreover, according to previous studies, Map3k1 was the most likely mutated gene in B6-Co mice; however, no mutated sites were identified by sequencing (data not shown) (Warr et al., 2011) . The mapping region possibly contains errors, because it is probably based on linkage disequilibrium in heredity. Therefore, we expanded the region to search for mutated genes; however, no mutations were observed in the Plk2 gene (data not shown) but in the Fgf10 (Figure 7A -E) and Mtap1B ( Figure 7H ) genes. The mutant sites of Fgf10 and Mtap1B were not observed in all B6-Co samples (Table 2) . However, the effect of these genes cannot be dismissed, because it is evident that the combined action of the environment and genes combine to generate the EOB phenotype. The regulation of multiple genes is possible in B6-Co mice, and further studies are needed to elucidate the genetic mechanism. Interestingly, there are no reports concerning genes related to the EOB phenotype in our mapping region, besides Map3k1 and Plk2. Therefore, it is possible that there are some mutated sites in vast noncoding regions or unknown functionally deficient genes in B6-Co mice.
Hbegf mRNA levels were significantly down-regulated at E16.5 in B6-Co eyelid tissues (P < 0.05). However, the difference was not significant at E18.5 (Figure 8 ). We propose that various genes regulate different eyelid development stages. The B6-Co eyelid phenotype was similar to that observed in Hbegf-deficient mice, but abnormal eyelid development in both models is induced by different mechanisms.
Mouse embryonic eyelid closure, involving the movement of epithelial sheets, is a tissue morphogenetic process occurring in several physiological or pathological procedures. Many signaling pathways controlling eyelid closure might also be effective in epidermal wound healing and tumorigenesis, both requiring epithelial cell migration and morphogenesis. It is therefore not surprising that c-Jun-null mice showed reduced skin wound healing and tumor formation (Xia and Kao, 2004) . Future studies should therefore explore the mechanism of action of important factors related to skin wound healing, as well as potential drug targets to treat impaired eyelid development. Ideally, eyelid closure should be achieved in mice exhibiting the EOB phenotype following treatment with various factors. There are few reports about eyelid function and eye accessory organs in adult EOB mice, because many studies have been focused on eyelid development at various embryonic stages. A previous study reported that shrinkage of the harderian gland in Fgf10 mutant mice could lead to corneal disease, due to defects in eyeball wetting (Puk et al., 2009 ). In conclusion, studies on eyelid function in EOB models would promote early diagnosis, prevention, and therapy for human heredity congenital eye disease, and development of relevant drugs. Furthermore, it could provide effective methods to understand and study human ocular diseases.
